STARD3 study for colorectal cancer patients
Part of Cancer, Digestive system clinical trials.
This study looks at a marker called STARD3 in colorectal cancer to understand its role and potential for targeted treatment. It may help find new ways to treat the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colorectal cancer, at any stage.
- You are 18 years or older.
- You are willing to sign a consent form.
- You have tumor tissue and blood samples stored in the hospital's biobank that can be used for research.
- You are not pregnant or breastfeeding.
- You have not had another cancer (except certain skin or cervical cancers) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This trial is for people with stage III colorectal cancer who haven't had treatment yet. It tests a blood test to find tiny bits of cancer DNA (MRD) after surgery, which may help doctors know if more treatment is needed.
This study looks at colorectal cancer patients who are planning curative surgery and collects related outcomes and lab “biomarker” information to better understand the disease. Your participation may help researchers connect test results to treatment results over time.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This trial tests a new drug called CC-3, which is a type of antibody designed to help your immune system attack colorectal cancer cells. It is for people whose cancer has spread and who have already tried several standard treatments.
This study uses a blood test to check for tumor DNA after surgery, which may help doctors decide if you need additional chemotherapy. It is for people with stage 3 colorectal cancer that is removed by surgery.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.